Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Non Invasive Prenatal Testing Companies

Non-invasive prenatal testing (NIPT) is a type of prenatal screening that involves analyzing cell-free DNA (cfDNA) from the mother's blood to assess the risk of certain chromosomal abnormalities in the fetus. Several companies specialize in offering NIPT services, and they play a crucial role in providing expectant parents and healthcare professionals with valuable information about the health of the developing fetus.

Non-Invasive Prenatal Testing (NIPT) Key CompaniesLatest Non-Invasive Prenatal Testing Companies Update

Nov 2023: The Global Health Access Initiative was launched by Illumina Inc., a leader in DNA sequencing and array-based technologies globally, to assist public health in low- and middle-income countries by providing access to pathogen sequencing tools. The initiative, created with input from clients, investors, and market intermediaries such as the nonprofit organization FIND, will offer qualified global health funding organizations discounted pricing structures for Illumina's qualifying sequencing products and tackle significant global logistics and supply chain issues. The cost of sequencing equipment and consumables can now differ by nation or area, which presents a problem for funders and donors and may prevent widespread adoption.


Nov 2023: To develop an assay for pre-transplant kidney testing, Verici Dx, a business that develops innovative clinical diagnostics for organ transplant, has partnered with Thermo Fisher, a global leader in healthcare, on a licensing basis. In addition to global rights, Thermo Fisher's exclusive license allows it to create and provide an assay for pre-transplant risk evaluation as a laboratory-developed test (LDT) at its CLIA laboratory in the United States. According to both businesses, the goal is to create a test that can categorize patients into risk groups according to how their immune systems are expected to react to kidney transplants. Consequently, physicians could be better equipped to decide how best to manage immunosuppressive and post-transplant patients.


List of Non-Invasive Prenatal Testing Key companies in the market

  • Illumina, Inc. (US)

  • Thermo Fisher Scientific, Inc. (US)

  • General Electric Company [GE Healthcare] (US)

  • Perkinelmer, Inc. (US)

  • Agilent Technologies, Inc. (US)

  • Beijing Genomics Institute (China)

  • Hoffman-La Roche Ltd. (Switzerland)

  • Tarsa Therapeutics, Inc. (US)

  • PhytoHealth Corporation (Taiwan)

  • Laboratory Corporation of America Holdings (US)

  • Natera, Inc. (US)

  • Yourgene Health (UK)

  • Centogene Holding AG [CENTOGENE AG ] (Germany)

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.